The role of filaggrin in the atopic diathesis

Clinical and Experimental Allergy

Volumn 40, Issue 7, 2010, Pages 965-972

  O'Regan, G M ^a   Irvine, A D ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FILAGGRIN; IMMUNOGLOBULIN E; STRUCTURAL PROTEIN;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ATOPIC DERMATITIS; ATOPY; CHILD; FAMILY STUDY; FOOD; HOMEOSTASIS; HUMAN; IMMUNE DYSREGULATION; LOSS OF FUNCTION MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SENSITIZATION; SKIN DEFECT; SKIN FUNCTION; TH1 CELL; TH2 CELL;

ANIMALS; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS;

EID: 77953490095     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03522.x     Document Type: Review

References (75)

1. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 446.
2. Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008 121 : 1203 1209.
3. Brown SJ, Relton CL, Liao H et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol 2008 121 : 940 946.
4. Sandilands A, O'Regan GM, Liao H et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 2006 126 : 1770 1775.
5. Smith FJ, Irvine AD, Terron-Kwiatkowski A et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006 38 : 337 342.
6. Ekelund E, Lieden A, Link J et al. Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish families. Acta Dermatol Venereol 2008 88 : 15 9.
7. Barker JN, Palmer CN, Zhao Y et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007 127 : 564 567.
8. Baurecht H, Irvine AD, Novak N et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007 120 : 1406 1412.
9. Chen H, Ho JC, Sandilands A et al. Unique and recurrent mutations in the filaggrin gene in Singaporean Chinese patients with ichthyosis vulgaris. J Invest Dermatol 2008 128 : 1669 1675.
10. Hamada T, Sandilands A, Fukuda S et al. De novo occurrence of the filaggrin mutation p.R501X with prevalent mutation c.3321delA in a Japanese family with ichthyosis vulgaris complicated by atopic dermatitis. J Invest Dermatol 2008 128 : 1323 1325.
11. Henderson J, Northstone K, Lee SP et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008 121 : 872 877.
12. Kang TW, Lee JS, Oh SW, Kim SC. Filaggrin mutation c.3321delA in a Korean patient with ichthyosis vulgaris and atopic dermatitis. Dermatology 2009 218 : 186 187.
13. Nomura T, Akiyama M, Sandilands A et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol 2008 128 : 1436 1441.
14. Oji V, Seller N, Sandilands A et al. Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroup. Br J Dermatol 2009 160 : 771 778.
15. Sinclair C, O'Toole EA, Paige D et al. Filaggrin mutations are associated with ichthyosis vulgaris in the Bangladeshi population. Br J Dermatol 2009 160 : 1113 1115.
16. Hsu CK, Akiyama M, Nemoto-Hasebe I et al. Analysis of Taiwanese ichthyosis vulgaris families further demonstrates differences in FLG mutations between European and Asian populations. Br J Dermatol 2009 161 : 448 451.
17. Djian P, Easley K, Green H. Targeted ablation of the murine involucrin gene. J Cell Biol 2000 151 : 381 388.
18. Koch PJ, de Viragh PA, Scharer E et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000 151 : 389 400.
19. Sevilla LM, Nachat R, Groot KR et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol 2007 179 : 1599 1612.
20. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005 6 : 328 340.
21. Backendorf C, Hohl D. A common origin for cornified envelope proteins?. Nat Genet 1992 2 : 91.
22. Glaser R, Meyer-Hoffert U, Harder J et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009 129 : 641 649.
23. Kalinin AE, Kajava AV, Steinert PM. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002 24 : 789 800.
24. List K, Szabo R, Wertz PW et al. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 2003 163 : 901 910.
25. Leyvraz C, Charles RP, Rubera I et al. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 2005 170 : 487 496.
26. Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009 122 : 1285 1294.
27. Epp N, Fürstenberger G, Müller K et al. 12R-lipoxygenase deficiency disrupts epidermal barrier function. J Cell Biol 2007 177 : 173 182.
28. Ginger RS, Blachford S, Rowland J, Rowson M, Harding CR. Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res 2005 297 : 235 241.
29. Gan SQ, McBride OW, Idler WW, Markova N, Steinert PM. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 1990 29 : 9432 9440.
30. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 25 : 141 142.
31. Denecker G, Hoste E, Gilbert B et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007 9 : 666 674.
32. Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J Cell Biol 2008 180 : 451 458.
33. Nicotera P, Melino G. Caspase-14 and epidermis maturation. Nat Cell Biol 2007 9 : 621 622.
34. Kamata Y, Taniguchi A, Yamamoto M et al. Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem 2009 284 : 12829 12836.
35. Pearton DJ, Dale BA, Presland RB. Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 2002 119 : 661 669.
36. Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 2007 127 : 1282 1284.
37. Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001 29 : 175 178.
38. Weidinger S, Baurecht H, Wagenpfeil S et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 2008 122 : 560 568.
39. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007 120 : 150 155.
40. Rawlings AV, Matts PJ. Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J Invest Dermatol 2005 124 : 1099 1110.
41. Rawlings AV, Scott IR, Harding CR, Bowser PA. Stratum corneum moisturization at the molecular level. J Invest Dermatol 1994 103 : 731 734.
42. Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986 115 : 84 92.
43. Kezic S, Kemperman PM, Koster ES et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008 128 : 2117 2119.
44. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008 122 : 689 693.
45. Sinclair C, O'Toole EA, Paige D et al. Filaggrin mutations are associated with ichthyosis vulgaris in the Bangladeshi population. Br J Dermatol 2009 160 : 1113 1115.
46. Irvine AD. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007 127 : 504 507.
47. Rodriguez E, Baurecht H, Herberich E et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009 123 : 1361 1370.
48. Ruether A, Stoll M, Schwarz T, Schreiber S, Folster-Holst R. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006 155 : 1093 1094.
49. Palmer CN, Ismail T, Lee SP et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 2007 120 : 64 8.
50. De Benedetto A, Qualia CM, Baroody FM, Beck LA. Filaggrin expression in oral, nasal, and esophageal mucosa. J Invest Dermatol 2008 128 : 1594 1597.
51. Bieber T. Atopic dermatitis. N Engl J Med 2008 358 : 1483 1494.
52. Boralevi F, Hubiche T, Leaute-Labreze C et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants - determining the role of epidermal barrier impairment. Allergy 2008 63 : 205 210.
53. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004 4 : 978 988.
54. Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009 41 : 602 608.
55. Scharschmidt TC, Man MQ, Hatano Y et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009 124 : 496 506.
56. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000 115 : 1072 1081.
57. Fartasch M, Bassukas ID, Diepgen TL. Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br J Dermatol 1993 128 : 1 9.
58. Behne MJ, Meyer JW, Hanson KM et al. NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem 2002 277 : 47399 47406.
59. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001 117 : 44 51.
60. Sonkoly E, Muller A, Lauerma AI et al. Homey B.IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006 117 : 411 417.
61. Jeong SK, Kim HJ, Youm JK et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008 128 : 1930 1939.
62. Vergnolle N, Bunnett NW, Sharkey KA et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001 7 : 821 826.
63. Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect danger: aiding the immune response. Allergy 2008 63 : 1110 1123.
64. Ebner S, Nguyen VA, Forstner M et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol 2007 119 : 982 990.
65. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002 3 : 673 680.
66. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006 203 : 269 273.
67. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007 204 : 1837 1834.
68. Di Cesare A, Di Meglio P, Nestle FO. A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 2008 128 : 2569 2571.
69. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008 128 : 2625 2630.
70. Briot A, Deraison C, Lacroix M et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009 206 : 1135 1147.
71. Bonnart C, Deraison C, Lacroix M et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010 120 : 871 882.
72. Jin H, Oyoshi MK, Le Y et al. IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Invest 2009 119 : 47 60.
73. Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009 129 : 1892 1908.
74. Katagiri C, Sato J, Nomura J, Denda M. Changes in environmental humidity affect the water-holding property of the stratum corneum and its free amino acid content, and the expression of filaggrin in the epidermis of hairless mice. J Dermatol Sci 2003 31 : 29 35.
75. Strid J, Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 2005 4 : 531 541.